Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Weldon

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 15, 2021
Caregiver exposure to hepatitis C virus following transplantation with hepatitis C viremic donor organs: A case seriesMichelle Kim, Jeffrey Stern, Ryan Robalino, et al.
The Journal of Pediatrics|September 1, 1987
Multiple sclerosis in childhood: clinical profile in 125 patientsP Duquette, T J Murray, J Pleines, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 21, 2024
Prophylactic 2-week Glecaprevir/Pibrentasvir in Hepatitis C positive to negative kidney transplantationRebecca A Dieter, Aprajita Mattoo, Perry Hotchkis, et al.
Transplantation Direct|January 13, 2025
Clinical Outcomes and Donor-specific Antibody Rebound 5 y After Kidney Transplant Enabled by Imlifidase DesensitizationIan S Jaffe, Anna Runström, Vasishta S Tatapudi, et al.
Annals of Surgery|July 14, 2018
IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific AntibodyBonnie E Lonze, Vasishta S Tatapudi, Elaina P Weldon, et al.
Critical Care Medicine|May 18, 2022
A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With HyperinflammationBonnie E Lonze, Peter Spiegler, Russell N Wesson, et al.
Transplantation Direct|September 13, 2021
Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C InfectionsZoe A Stewart, Jeffrey Stern, Nicole M Ali, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Coordinated circulating and tissue-based T cell responses precede xenograft rejectionEkaterina Novikova, Elizabeth Severa, Han Chen, et al.
Nature Medicine|July 24, 2023
Pig-to-human heart xenotransplantation in two recently deceased human recipientsNader Moazami, Jeffrey M Stern, Karen Khalil, et al.
Nature|November 13, 2025
Physiology and immunology of a pig-to-human decedent kidney xenotransplantRobert A Montgomery, Jeffrey M Stern, Farshid Fathi, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 15, 2021
Caregiver exposure to hepatitis C virus following transplantation with hepatitis C viremic donor organs: A case seriesMichelle Kim, Jeffrey Stern, Ryan Robalino, et al.
The Journal of Pediatrics|September 1, 1987
Multiple sclerosis in childhood: clinical profile in 125 patientsP Duquette, T J Murray, J Pleines, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 21, 2024
Prophylactic 2-week Glecaprevir/Pibrentasvir in Hepatitis C positive to negative kidney transplantationRebecca A Dieter, Aprajita Mattoo, Perry Hotchkis, et al.
Transplantation Direct|January 13, 2025
Clinical Outcomes and Donor-specific Antibody Rebound 5 y After Kidney Transplant Enabled by Imlifidase DesensitizationIan S Jaffe, Anna Runström, Vasishta S Tatapudi, et al.
Annals of Surgery|July 14, 2018
IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific AntibodyBonnie E Lonze, Vasishta S Tatapudi, Elaina P Weldon, et al.
Critical Care Medicine|May 18, 2022
A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With HyperinflammationBonnie E Lonze, Peter Spiegler, Russell N Wesson, et al.
Transplantation Direct|September 13, 2021
Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C InfectionsZoe A Stewart, Jeffrey Stern, Nicole M Ali, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Coordinated circulating and tissue-based T cell responses precede xenograft rejectionEkaterina Novikova, Elizabeth Severa, Han Chen, et al.
Nature Medicine|July 24, 2023
Pig-to-human heart xenotransplantation in two recently deceased human recipientsNader Moazami, Jeffrey M Stern, Karen Khalil, et al.
Nature|November 13, 2025
Physiology and immunology of a pig-to-human decedent kidney xenotransplantRobert A Montgomery, Jeffrey M Stern, Farshid Fathi, et al.
Pageof 4